- Home
- ARWR vs IT Comparison
ARWR vs IT Comparison
Compare ARWR & IT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARWR | IT |
|---|---|---|
| Founded | 2003 | 1979 |
| Country | United States | United States |
| Employees | N/A | 40 |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.4B | 14.4B |
| IPO Year | 2009 | 2010 |
Fundamental Metrics
Financial Performance| Metric | ARWR | IT |
|---|---|---|
| Price | $59.98 | $235.76 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 15 | 15 |
| Target Price | $107.71 | ★ $193.77 |
| AVG Volume (30 Days) | ★ 1.7M | 839.6K |
| Earning Date | 11-24-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 99.80 | N/A |
| EPS | N/A | ★ 7.29 |
| Revenue | $16,142,321.00 | ★ $2,021,441,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.02 |
| P/E Ratio | ★ N/A | $31.37 |
| Revenue Growth | N/A | ★ 13.30 |
| 52 Week Low | $37.06 | $124.25 |
| 52 Week High | $95.49 | $256.90 |
Technical Indicators
Market Signals| Indicator | ARWR | IT |
|---|---|---|
| Relative Strength Index (RSI) | 42.08 | 69.30 |
| Support Level | $54.93 | $142.37 |
| Resistance Level | $66.37 | N/A |
| Average True Range (ATR) | 2.22 | 8.19 |
| MACD | 0.91 | 1.32 |
| Stochastic Oscillator | 71.90 | 94.45 |
Price Performance
Historical ComparisonAbout ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.
About IT Gartner Inc.
Gartner provides independent research and analysis on information technology for chief information officers and other business executives who help plan companies' IT budgets. Its flagship Magic Quadrant reports inform many enterprises of their IT procurement decisions. Gartner also provides consulting services and holds some of the largest conferences in the IT industry. Around 80% of Gartner's revenue is generated from industry research.